Celonic possesses comprehensive experience in the cultivation of eukaryotic cells like CHO-, Hybridoma- (NS0, NS1) as well as human (HEK293) cell lines typically used for the production of recombinant therapeutic proteins.
We offer a complete range of preclinical developments:

Frankfurt, 22-23 September 2010
Juelich receives GMP certificate

Challenging positions in development, production, downstream processing and quality control